Drug Profile
Tolterodine/pilocarpine
Alternative Names: THVD-201; THVD-202; TolenixLatest Information Update: 27 Sep 2021
Price :
$50
*
At a glance
- Originator TheraVida
- Developer SK Chemicals; TheraVida
- Class Alkaloids; Antispasmodics; Benzhydryl compounds; Cresols
- Mechanism of Action Muscarinic receptor agonists; Muscarinic receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Overactive bladder
Most Recent Events
- 27 Sep 2021 Discontinued - Phase-II for Overactive bladder in Australia, New Zealand (PO) (TheraVida pipeline, September 2021)
- 27 Sep 2021 Discontinued - Phase-III for Overactive bladder in South Korea (PO) (TheraVida pipeline, September 2021)
- 27 Sep 2021 Discontinued - Preclinical for Overactive bladder in USA (PO) (TheraVida pipeline, September 2021)